Updates in the Treatment of Secondary AML After the 2024 SOHO Annual Meeting - Episode 4
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss dose intensity and sequencing of CPX-351 in secondary acute myeloid leukemia.